M J Lopez1, W G Kraybill, R S Downey
1Department of Surgery, Ellis Fischel State Cancer Center, Columbia, MO 65203.
Total pelvic exenteration for rectosigmoid cancer offers a survival rate exceeding 40% at 5 years. This procedure, while having risks, shows decreasing mortality and acceptable morbidity in selected patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: